FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137511700> ?p ?o ?g. }

• W2137511700 abstract "In many tumors including ovarian cancer, cell proliferation and apoptosis are important in pathogenesis and there are many alterations in most of the genes related to the cell cycle. This study was designed to evaluate immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, and bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in typing of benign, borderline, and malignant serous and mucinous ovarian tumors.Total of 68 ovarian tumors, 25 benign [13 (19.1%) serous and 12 (17.6%) mucinous], 16 borderline [9 (13.2%) serous and 7(10.3%) mucinous], and 27 malignant ovarian tumors [24 (35.3%) serous and 3 (4.4%) mucinous tumors] were included in the study. Immunohistochemical expression of p53, p21, bax, bcl-2, telomerase, c-kit, and metallothionein were evaluated.When all 68 cases were evaluated as benign, borderline, and malignant ovarian tumors without considering histopathological subtypes, the p53, p21, bax and metallothionein showed significantly higher staining scores in the borderline and malignant ones (p < 0.05). After evaluation of all 68 cases, the serous tumors showed significantly higher staining scores of p53, p21, c-kit, and metallothionein compared to the mucinous ones (p < 0.05). For differentiation of benign and borderline and malignant tumors combined, p53 was not used because all benign tumors has no staining, and p21, bax, and metallothionein was determined the significant predictors for borderline and malignant tumors combined (p < 0.05). For differentiation of borderline and malignant tumors, only p53 was determined the significant predictor for malignant tumors (p < 0.05).In conclusion, p53, p21, bax, c-kit, and metallothionein may be helpful for the typing of ovarian tumors as benign, borderline and malignant or serous and mucinous. p53, p21, bax, c-kit, and metallothionein may have different roles in the pathogenesis of ovarian tumor types. p53 and metallothionein may be helpful in the typing of borderline and malignant ovarian tumors. The immunohistochemical staining with bcl-2 and telomerase may not provide meaningful contribution for the typing of ovarian tumors.The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2013030833768498." @default.
• W2137511700 created "2016-06-24" @default.
• W2137511700 creator A5002599264 @default.
• W2137511700 creator A5028189096 @default.
• W2137511700 creator A5041173294 @default.
• W2137511700 creator A5048659249 @default.
• W2137511700 creator A5053414366 @default.
• W2137511700 creator A5087881840 @default.
• W2137511700 date "2012-09-20" @default.
• W2137511700 modified "2023-09-30" @default.
• W2137511700 title "Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors" @default.
• W2137511700 cites W1539450772 @default.
• W2137511700 cites W1914677356 @default.
• W2137511700 cites W1973324549 @default.
• W2137511700 cites W1980571783 @default.
• W2137511700 cites W1989937700 @default.
• W2137511700 cites W1998385628 @default.
• W2137511700 cites W2012757973 @default.
• W2137511700 cites W2013848922 @default.
• W2137511700 cites W2017408894 @default.
• W2137511700 cites W2017697346 @default.
• W2137511700 cites W2018609544 @default.
• W2137511700 cites W2031209812 @default.
• W2137511700 cites W2031946544 @default.
• W2137511700 cites W2041663381 @default.
• W2137511700 cites W2045044155 @default.
• W2137511700 cites W2053263835 @default.
• W2137511700 cites W2056823481 @default.
• W2137511700 cites W2060063531 @default.
• W2137511700 cites W2064242747 @default.
• W2137511700 cites W2068019777 @default.
• W2137511700 cites W2075723141 @default.
• W2137511700 cites W2084033679 @default.
• W2137511700 cites W2084053337 @default.
• W2137511700 cites W2085000900 @default.
• W2137511700 cites W2085731614 @default.
• W2137511700 cites W2088344791 @default.
• W2137511700 cites W2102385652 @default.
• W2137511700 cites W2113085746 @default.
• W2137511700 cites W2121854757 @default.
• W2137511700 cites W2131098741 @default.
• W2137511700 cites W2143953518 @default.
• W2137511700 cites W2146965588 @default.
• W2137511700 cites W2147028372 @default.
• W2137511700 cites W2166514156 @default.
• W2137511700 cites W2227161527 @default.
• W2137511700 cites W2438489380 @default.
• W2137511700 doi "https://doi.org/10.1186/1746-1596-7-124" @default.
• W2137511700 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3523067" @default.
• W2137511700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22995373" @default.
• W2137511700 hasPublicationYear "2012" @default.
• W2137511700 type Work @default.
• W2137511700 sameAs 2137511700 @default.
• W2137511700 citedByCount "39" @default.
• W2137511700 countsByYear W21375117002013 @default.
• W2137511700 countsByYear W21375117002014 @default.
• W2137511700 countsByYear W21375117002015 @default.
• W2137511700 countsByYear W21375117002016 @default.
• W2137511700 countsByYear W21375117002017 @default.
• W2137511700 countsByYear W21375117002019 @default.
• W2137511700 countsByYear W21375117002020 @default.
• W2137511700 countsByYear W21375117002021 @default.
• W2137511700 countsByYear W21375117002022 @default.
• W2137511700 countsByYear W21375117002023 @default.
• W2137511700 crossrefType "journal-article" @default.
• W2137511700 hasAuthorship W2137511700A5002599264 @default.
• W2137511700 hasAuthorship W2137511700A5028189096 @default.
• W2137511700 hasAuthorship W2137511700A5041173294 @default.
• W2137511700 hasAuthorship W2137511700A5048659249 @default.
• W2137511700 hasAuthorship W2137511700A5053414366 @default.
• W2137511700 hasAuthorship W2137511700A5087881840 @default.
• W2137511700 hasBestOaLocation W21375117001 @default.
• W2137511700 hasConcept C104317684 @default.
• W2137511700 hasConcept C121608353 @default.
• W2137511700 hasConcept C126322002 @default.
• W2137511700 hasConcept C142724271 @default.
• W2137511700 hasConcept C150173356 @default.
• W2137511700 hasConcept C204232928 @default.
• W2137511700 hasConcept C20719415 @default.
• W2137511700 hasConcept C2780427987 @default.
• W2137511700 hasConcept C502942594 @default.
• W2137511700 hasConcept C55493867 @default.
• W2137511700 hasConcept C71924100 @default.
• W2137511700 hasConcept C86803240 @default.
• W2137511700 hasConcept C94581717 @default.
• W2137511700 hasConceptScore W2137511700C104317684 @default.
• W2137511700 hasConceptScore W2137511700C121608353 @default.
• W2137511700 hasConceptScore W2137511700C126322002 @default.
• W2137511700 hasConceptScore W2137511700C142724271 @default.
• W2137511700 hasConceptScore W2137511700C150173356 @default.
• W2137511700 hasConceptScore W2137511700C204232928 @default.
• W2137511700 hasConceptScore W2137511700C20719415 @default.
• W2137511700 hasConceptScore W2137511700C2780427987 @default.
• W2137511700 hasConceptScore W2137511700C502942594 @default.
• W2137511700 hasConceptScore W2137511700C55493867 @default.
• W2137511700 hasConceptScore W2137511700C71924100 @default.
• W2137511700 hasConceptScore W2137511700C86803240 @default.
• W2137511700 hasConceptScore W2137511700C94581717 @default.
• W2137511700 hasIssue "1" @default.
• W2137511700 hasLocation W21375117001 @default.

• next